Abstract
This study was designed using c-myc antisense transcripts to evaluate how alteration of c-myc expression in human myeloid leukemic HL-60 cells could influence the myelomonocytic differentiation and induction of apoptosis. The recombinant plasmid pDACx expressing antisense transcripts to c-myc fragment containing a part of intron 1 and 137 nt exon 2 was constructed, pDACx was transfected into HL-60 cell line by lipofectin reagent. Cytochemical stainings including NBT reduction, peroxidase and α -NAE as well as detection of CD13 and CD33 antigens by flow cytometric analysis indicated occurrence of myelomonocytic differentiation in cells expressing antisense transcripts to c-myc. DNA degradation measured by DNA gel electrophoresis and typical morphological changes observed under electron microscope proved the switch-on of apoptosis in terminally differentiating HL-60 cells.
Similar content being viewed by others
Introduction
The product of c-myc oncogene is a sort of oncoproteins that are closely related to malignant proliferation of tumor cells and as a transcriptional factor involved in the common pathway of proliferative signal transduction. It has been reported that overexpressed c-myc oncogene can promote cell growth in the presence of cytokines and induce apoptosis in the absence of cytokines1, 2. The reason might include the expression of different genes promoted by c-myc oncogene expression under different circumstances. Therefore, apoptosis and proliferation might be two independent processes that have their own modulation system of signal transduction though the updated experimental data are still insufficient. Antisense c-myc oligodeoxynucleotides have been used to study the effects of the downregulated c- myc expression on differentiation3 and apoptosis4. But what would happen in cell functional activities when c-myc oncogene expression decreased via transfection of recombinant plasmids expressing antisense c-myc transcripts? In the previous study, we investigated how cell proliferation was affected by the c-myc protein levels using antisense c-myc transcripts. In this article, inductions of terminal differentiation and apoptosis were observed.
Materials and Methods
Plasmids
pUC18 was purchased from Promega. pE-H (containing 8.08kb human c-myc cDNA gene) and retroviral expression vector pDORneo were all kindly provided by Institute for Cancer Research, Chinese Academy of Medical Sciences.
Construction of recombinant plsmids
2723bp DNA fragment containing exon 1, intron 1 and 137nt exon 2 were obtained from PstI- digested pE-H plasmid. XbaI-digested 2723 bp DNA fragment led to 5'-portion 1588bp fragment including exon 1 and a part of intron 1 and 3'-portion 1135 bp fragment including a part of intron 1 and 137nt exon 2. The 1135 bp fragment was ligated into the XbaI-Pst I sites of pUC18 according to the standard procedures5.
Cell culture and DNA transformation
The HL-60 myeloid leukemia cell line was kindly provided by Lisheng Wang (Institute of Radiation Medicine, Beijing) and maintained in suspension cultures in RPMI 1640 supplemented with 10% heat-inactivated bovine serum at 37 °C in a fully humidified atmosphere containing 5% CO2. Cells in exponential growth were used in this study. The HL-60 cells were transfected with the plasmid pDORneo and pDACx by means of lipofection (lipofectin reagent from Life Sciences Technologies, Inc. USA) and the transfectants were named as DH and CH cells respectively. G418 (Life Sciences Technologies, Inc. USA) was added to culture 48 h later.
Detection of c-myc protein
Translation of c-myc mRNA into p65 was detected by cell-in situ ELISA. Cells were seeded in poly-L-lysine pretreated 96-well plate at 4 °C overnight and fixed with 0.05% glutaraldehyde. After blocking, anti-p65 monoclonal antibody (C-33, Santa Cruz Biotechnology, USA) and HRP- conjugated sheep-anti-mouse IgG were added sequentially. Then they were developed by adding TMB and H2O2. The reaction was stopped with 12.5% sulfuric acid. The value of OD492 was measured.
Cytochemical stainings
NBT (Nitroblue tetrazolium) reaction, peroxidase and α -NAE -naphthol acetate esterase) stainings were performed according to standard procedures6. The average positive rates of stainings were calculated through counting the positive and the total cell numbers of several vision fields under, microscope in three tests.
Expressions of differentiation antigens CD13 and CD336
Cells 1.5×106 were mixed with 1:10 diluted anti-CD13 and anti- CD33 monoclonal antibod- ies (DAKO, Danmark) and reacted at 4 °C for 40 minutes. After washing, 1:10 diluted FITC- conjugated rabbit-anti-mouse IgG was added to 100 μl cell suspension and incubated in dark at 4 °C for 40 minutes. Cells were then analysed with FACS-440 (Becton Dickinson, USA).
DNA fragmentation
DNA was extracted from pDOR/HL-60 (DH) and pDACx/HL-60 (CH) cells by salting-out method7 after 5 to 6 d of transfection. DNA agarose gel electrophoresis was carried out as commonly described5. About 20 μg DNA in 1×TBE buffered 1.3% agarose gel was electrophoresed at 35V for about 10 h.
Morphology
Ultrastructural features of HL-60 cells transfected and G418-treated were observed 5 to 12 d posttransfection under transmission electron microscope (TEM). In addition, the changes on the surfaces of cells in each group were also studied by scanning electron microscope (SEM).
Results
Construction of recombinant plasmids pUC18-PX and pDACx
Fig 1 outlined the construction of pDACx. Fig 2 shows the recovery of the useful c-myc fragments through restriction enzyme digestions. According to the physical map of pE-H, we used Pst I and Xba I to obtain the fragments of interest as described in MATERIALS and METHODS. In lane 2 of Fig 2, most of the 2723bp Pst I-fragments were cleaved by Xba I into 1588bp and l135bp fragments, and the 1710bp and 1588bp were not separated in that electrophoresis. But what we are interested in is l135bp fragment. The l135bp (roughly 1.2kb) fragment was recovered from the gel and then ligated into pDORneo in antisense orientation called pDACx. The pUC18-PX and pDACx were further proved by restriction enzyme digestions, which is shown in Fig 3.
Expression level of p65
OD492 value of DH cells was 0.836+0.03 while that of CH cells was 0.228+0.02. The results indicated that the level of c-myc product decreased about 3.7 times at the 6th day posttransfection through expression of antisense transcripts to c-myc.
Decreased c-myc expression by antisense c-myc RNA accelerated myelomonocytic differentiation in CH cells
The occurrence of myelomonocytic differentiation in CH cells as revealed by the cytochemical staining of esterases and peroxidase
The average positive rate of NBT reduction of CH cells markedly increased at the 4th day post transfection, from about 0.5–1.5% in DH cells to about 20-40% in CH cells. After the 6th day the positive rate began to decrease and gradually disappeared. The average positive rate of peroxidase-stained CH cells was 60-80% at the 5th day as compared with 10-20% in DH cells. Morever, the positive particles in CH cells were more and larger and those in DH cells were less and smaller. The peroxidase staining became negative till the 8th day. Positive results were also observed in CH cells with α-NAE staining.
The alterations of CD13 and CD33 antigen expression during myelomonocytic differentiation
Tab 1 shows the expression levels of CD13 and CD33 antigens in DH and CH cells. It could be seen that both the positive rate of CD13 antigen which defines myelomonocytic differentiation at the 4th day posttransfection and the average fluorescence intensity that indicates the density of CD13 antigen on each positive cell increased. Meanwhile, expression of CD33 antigen existing only in eariler myeloid progenitor cells decreased8. But on the 6th day posttransfection expression of CD13 antigen decreased and that of CD33 decreased further. The transiently increased CD13 expression and decreased CD33 expression in CH cells on the 4th day suggested that myelomonocytic differentiation could be induced in c-myc downregulated CH cells. The changes of differentiation antigen expression were in consistent with those of cytochemical stainings both in time and the results.
Apoptosis occurred following terminal differentiation in CH cells
Nuclear DNA degradation
To seek for the reasons why increased CD13 expression soon went downwards on the 6th day after transfection, cell genomic DNA from DH and CH were analysed through agarose gel electrophoresis to examine the integrity of chromosome DNA. Fig 4 shows the results of DNA gel electrophoresis of DH and CH cells 5 days after transfection. DNA ladder bands with integer multiples of 180-200 base pairs were obviously seen in CH cells whereas no such ladder bands in DH cells.
Apoptotic morphological alterations
Fig 5 shows the ultrastructural features of DH, G418-treated DH and CH cells observed under TEM. From the 5th day post transfection condensed heterochromatin in several crescent clumps that abutted against the nuclear envelope was observed in CH cells. The cytoplasmic membrane remained intact, organelles were atropied while enormous vacuoles and pultaceous bodies appeared in cytoplasm of the CH cells. The condensed nuclei were then further degraded, broken, moved out of the cells, and finally were encapsulated to form apoptotic bodies. This was consistent with the previous observations9, 10. On the contrary, the morphological features of G418-treated DH cells were extreme dilation of endoplasmic reticula, destruction of mitochondria, collapse of cytoplasmic membrane and no obvious changes in chromatin and nuclear membrane (Fig 5A). The alterations in the surfaces of apoptotic cells under SEM have not been reported sofar (Fig 6). Enormous finger-like protuberances were seen on the surface of DH cells. However in that of CH cells the atrophy, smooth yet intact cytoplasmic membrane and sometimes the large concave regions, and clumpy projections were observed.
Discussion
We transfected HL-60 cells with recombinant plasmids expressing antisense c- myc RNA to examine the effects of antisense c-myc transcripts on cell differentiation and survival. It has been reported that the c-myc oncogene was dominantly overexpressed in the poorly-differentiated cell lines, and contributed to the malignant proliferation and block of differentiation. It is commonly held decreased c-myc expression may cause differentiation. This study intended to add some answers to this question. Our experiments have shown that decrease of CD33, increase of CD13 expression, NBT reduction and functional activities of some enzymes such as α-naphthol acetate esterase and peroxidase were detected in CH cells, while no such alterations were observed in DH cells and HL-60 cells. There were no significant differences in morphology, enzymes activities and surface antigen expression between DH and HL-60 cells. It suggested that myelomonocytic differentiation occurred after p65 was downregulated through the expression of c-myc antisense transcripts. The amount of c-myc mRNA decreased during the HL-60 cells being induced to differentiate into granulocytes and monocyte-macrophages11. Terminal myelomonocytic differentiation was observed in this study along with the decreased c-myc expression. Thus the level of c-myc expression was closely correlated with myelomonocytic differentiation.
The result of DNA gel electrophoresis revealed non-random degradation of genomic DNA structure, which signified the destined death of these cells. The regular DNA ladder bands revealed in electrophoresis could provide the evidence for cell apoptosis. It was reported that this patterns of DNA ladder bands came from the specific cleavage of chromosome DNA at the linkage of internucleosomes due to the activation of endonuclease in the early process of apoptosis12. The occurrence of DNA ladder bands suggested that endogenous endonuclease had been activated during apoptosis of CH cells. In morphological study, besides DH cells, we used G418-treated cells as controls to observe the morphological changes caused by c- myc antisense transcripts on HL-60 cells so as to emphasize that the morphological features of CH cells are unique, which is the characteristics of apoptosis but not necrosis as observed in G418-treated cells.
The relationship between the alteration in c-myc expression and differentiation and apoptosis has been studied previously3, 13. Although some investigators reported that the up-regulation of c-myc expression caused apoptosis13 while others suggested that down-regulation may be necessary for the induction of apoptosis14, both of them were correct under different circumstances. Apoptosis is the result of multiple factors and their interactions. Studies showed bcl-2 gene expression level decreased after differentiation of HL-60 cells15. With the deprivation of bcl-2- inhibited apoptosis pathway, cells went to apoptosis. Therefore, differentiation was accompanied by apoptosis in HL-60 cells and bcl-2 may play an important role in this process. Yet bcl-2 itself did not have any effect on differentiation16. That the abrupt decrease of c-myc level in overexpressed HL-60 cells switched on the process of apoptosis was somewhat easy to understand due to the induction of differentiation. In addition, p53 may also be involved in this process. Lotem et al1 reported that c-myc related apoptosis was not the direct result of deregulated c-myc expression but that c-myc expression increased cell's sensitivity to apoptosis and this sensitivity can be inhibited by the overexpressed mutant p53 and bcl-2 gene products.
From our results, it is concluded that in HL-60 cells transfected with c-myc antisense transcripts the following changes were observed: (i) the endogenous p65 expression was repressed; (ii) the decrease in p65 resulted in the increased expression of the myelomonocytic differentiating cell surface marker CD13, increased NBT reduction, positive peroxidase and α -NAE stainings; (iii) DNA degradation and typical morphological changes suggesting apoptosis. Therefore, it appears that the decreased c-myc expression might be one of the causes of induced terminal differentiation and apoptosis in HL-60 cells.
References
Lotem J, Sachs L . Regulation by bcl-2, c-myc and p53 of susceptibility to induction of apoptosis by heat shock and cancer chemotherapy compounds in differentiation competent and defective myeloid leukemia cells. Cell Growth Differ 1993; 4:41–9
Sachs L, Lotem J . Control of programmed cell death in normal and leukemia cells: new applications for therapy. Blood 1993; 82:15–21
Holt JT, Rendner RL and Nienhuis AW . An oligomer complementary to c-myc mRNA inhibits proliferation of HL-60 promyelocytic cells and induces differentiation. Mol Cell Biol 1988; 8:963–73
Kimura S, Maekawa T, Hirakawa K, et al. Alterations of c-myc expression by antisense oligodeoxy nucleotides enhanced the induction of apoptosis in HL-60 cells. Cancer Res 1995; 55:1379–84
Sambrook J, Pritsch EF, Maniatis T . Molecular Cloning: A Laboratory Manual. 2nd ed. New York: Cold Spring Harbor Laboratory Press. 1989
Kamano H, Ohnishi H, Tanaka T, et al. Effects of the antisense v-myb expression on K562 human leukemia cell proliferation and differentiation. Leuk Res 1990; 14:831–9
Miller SA, Dykes DD, Polesky HF . A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988; 16:1215–8
Andrews RG, Singer JW and Bernstein ID . Precursors of colony-forming cells in humans can be distinguished from colony-forming cells by expression of the CD33 and CD34 antigens and light scatter properties. J Exp Med 1989; 169:1721–31.
Ormerod MG . Flow cytometric studies of apoptosis. CMB 1994; 1:35–43
Bergamashi G, Rosti V, Danova M, et al. Apoptosis: biological and clinical aspects. Haematologica 1994; 79:86–93
Koeffer HP . Induction of differentiation of human acute myelogenous leukemia cells: therapeutic implications. Blood 1983; 62:709–21.
Fernandes RS and Cotter TG . Activation of a calcium magnesium independent endonuclease in human leukemia cell apoptosis. Anticancer Res 1993; 13:1253–60
Shi Y, Glynn JM, Guilbert LJ, et al. Role for c-myc in activation-induced apoptotic cell death in T cell hybridomas. Science 1992; 257:212–4
Alnemri ES, Fernandes TF, Haldar S, et al. Involvement of BCL-2 in glucocorticoid-induced apoptosis of human pre-B-leukemias. Cancer Res 1992; 52:491–8
Delia D, Aliello A, Soligo D, et al. Bcl-2 proto-oncogene expression in normal and neoplasic human myeloid cells. Blood 1992; 79:1291–8
Naumovski L, Cleary ML . Bcl-2 inhibits apoptosis associated with terminal differentiation of HL-60 myeloid leukemia cells. Blood 1994; 83:2261–7
Acknowledgements
We thank Mr. Zhang Lianfeng, Wang Zhihua and Wang Xiuqin from Institute of Cancer Research, Chinese Academy of Medical Sciences for helping in plasmid construction.
Author information
Authors and Affiliations
Additional information
This work was supported by the National Medical and Scientific Key Item Grant
Rights and permissions
About this article
Cite this article
Hao, X., Tang, P., Li, X. et al. Abrupt decrease of c-myc expression by antisense transcripts induces terminal differentiation and apoptosis in human promyelocytic leukemia HL-60 cells. Cell Res 6, 189–199 (1996). https://doi.org/10.1038/cr.1996.20
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/cr.1996.20